Bank of America
INSY

Bank of America’s Insys Therapeutics, Inc. INSY Stock Holding History

Bank of America’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-61,600
Closed -$797K – 7510
2016
Q2 		$797K Buy
+61,600
New +$898K ﹤0.01% 4334

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Bank of America's INSY Position: Q2 2019 in Review

Bank of America sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 31,257 shares — an estimated $144K sold.

Bank of America first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $4.93M in Q4 2013. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Bank of America reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Bank of America sold 31,257 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $144K.
  • Bank of America first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
  • Bank of America's Insys Therapeutics, Inc. position peaked at $4.93M in Q4 2013.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.